FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...o-McNeil-Janssen Pharmaceuticals, Inc, will market invega SUSTENNA in the U.S. An estimated one perce...h, M.D., a clinical investigator who worked on the invega SUSTENNA clinical trials, and a Professor of Psych...College of Medicine. "The approval of once-monthly invega SUSTENNA will provide healthcare professionals wit...

Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia

...mptions driving these models. Patient-flow analysis for Janssen's invega shows that only three percent of all users took the drug as a first-line ag...tially increase their first- and second-line prescriptions for the drug. As invega continues to experience increased uptake in early lines of therapy, surveye...

Johnson & Johnson Reports 2009 First-Quarter Results:

...ved for the treatment of a number of immune mediated inflammatory diseases; invega and RISPERDAL CONSTA, both antipsychotic medications; and VELCADE, a treatm... U.S. Food and Drug Administration (FDA) requesting approval for the use of invega tablets for the treatment of schizoaffective disorder as monotherapy and fo...

INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia

...n those patients that transitioned from placebo to invega and were maintained in those that were previously on invega as assessed by the Positive and Negative Symptoms ...s to the body of knowledge regarding the safety of invega in the longer-term treatment of schizophrenia. The...

Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate

.... The most common side effects that occurred with invega were restlessness and extrapyramidal disorder (for...ments, tremors and muscle stiffness). One risk of invega is that it may change your heart rhythm. This effe...re and potentially fatal side effect reported with invega and similar medicines. Call your doctor immediatel...

INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia

...to deliver paliperidone - the active ingredient in invega - through the innovative osmotic delivery system (OROS(R)). In clinical trials, invega demonstrated significant efficacy as compared to p...U.S., this product is marketed by Janssen, L.P. as invega (paliperidone) Extended-Release Tablets. This appr...

INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia

...to deliver paliperidone - the active ingredient in invega - through the innovative osmotic delivery system (OROS(R)). In clinical trials, invega demonstrated significant efficacy as compared to p...U.S., this product is marketed by Janssen, L.P. as invega (paliperidone) Extended-Release Tablets. This appr...

INVEGA in Medical Technology

Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control

52-Week Trial Maintained Improvement in Personal and Social Performance COLORADO SPRINGS, Colo., March 30, 2007 /PRNewswire/ -- Longer-term treatment with INVEGA(TM) (paliperidone) Extended-Release Tablets, a new once daily oral medication for schizophrenia, helped many patients effectiv...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...ormation. IMPORTANT SAFETY INFORMATION FOR invega ((R)) SUSTENNA(TM) invega ((R)) SUSTENNA(TM) is not approved for the trea...y patients who were given oral antipsychotics like invega ((R)) SUSTENNA(TM) in clinical studies for psyc...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

...DAs) to the FDA requesting approval for the use of invega tablets for the treatment of schizoaffective disor... studies that evaluated the efficacy and safety of invega in patients with schizoaffective disorder. If approved by the FDA, invega would be the only medication indicated to treat th...

INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients

...and placebo. Symptom improvement was observed with invega as early as five days into therapy and continued t...st two weeks of the study. The results showed that invega achieved a significant reduction of symptoms of ac...zophrenia. This trial showed beneficial effects of invega in severely ill, hospitalized patients with an acu...

INVEGA in Biological Technology

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

...Release Tablets, the oral formulation of paliperidone, was first approved in 2006 in the U.S. for the acute treatment of schizophrenia. In March 2007, invega was approved for the maintenance treatment of schizophrenia in the U.S. It was also approved for the treatment of schizophrenia in the European Union ...

Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress

... at the Gaylord Palms Resort & Convention Center. invega is an atypical antipsychotic medication approved f.... The most common side effects that occurred with invega were restlessness and extrapyramidal disorder (for...ements, tremors and muscle stiffness). One risk of invega is that it may change your heart rhythm. This effe...